Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EBEWE Pharma (Generic Injectables Business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of generic oncology medicines. The business unit manufactures generic medicines such as paclitaxel, epirubicin, methotrexate, oxaliplatin, carboplatin, doxorubicin and gemcitabine for the treatment of many types of cancers.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Unterach
  • Austria

EBEWE Pharma (Generic Injectables Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore EBEWE Pharma (Generic Injectables Business)‘s full profile, request access.

Request full access to PitchBook

EBEWE Pharma (Generic Injectables Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore EBEWE Pharma (Generic Injectables Business)‘s full profile, request access.

Request full access to PitchBook